Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage -: Role of endogenous IL-1 inhibitors

被引:133
作者
Vuolteenaho, K
Moilanen, T
Hämäläinen, M
Moilanen, E [1 ]
机构
[1] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FI-33014 Tampere, Finland
[2] Tampere Univ Hosp, Tampere, Finland
[3] Coxa Hosp Joint Replacement, Tampere, Finland
基金
芬兰科学院;
关键词
nitric oxide; osteoarthritis; rheumatoid arthritis; interleukin-1;
D O I
10.1080/03009740310000355
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: To investigate the endogenous regulation of interleukin-1 (IL-1) cytokine network in osteoarthritic (OA) and rheumatoid (RA) cartilage in relation to nitric oxide (NO) production. Methods: Cartilage specimen obtained from OA and RA patients undergoing knee replacement surgery were studied for iNOS expression, NO and IL-1 antagonist production in tissue culture. Results: OA cartilage responded to IL-1beta-stimulation with higher NO production than RA cartilage, whereas there was no difference in NO synthesis between OA and RA samples when stimulated by TNFalpha or LPS. Interleukin-1 receptor antagonist (IL-1Ralpha) production was higher in RA cartilage than in OA cartilage, and its production was increased by NO synthase inhibitor 1400W. Conclusion: IL-1beta is a potent stimulator of NO production by the iNOS pathway in RA and more pronouncedly in OA cartilage. This process is regulated by cartilage derived IL-1 antagonists, and is implicated in cartilage destruction and synovial inflammation in OA and RA joints.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 52 条
[1]
THE EXPRESSION AND REGULATION OF NITRIC-OXIDE SYNTHASE IN HUMAN OSTEOARTHRITIS-AFFECTED CHONDROCYTES - EVIDENCE FOR UP-REGULATED NEURONAL NITRIC-OXIDE SYNTHASE [J].
AMIN, AR ;
DICESARE, PE ;
VYAS, P ;
ATTUR, M ;
TZENG, E ;
BILLAR, TR ;
STUCHIN, SA ;
ABRAMSON, SB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :2097-2102
[2]
Attur MG, 1998, P ASSOC AM PHYSICIAN, V110, P65
[3]
BLANCO FJ, 1995, AM J PATHOL, V146, P75
[4]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]
Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: Prolyl hydroxylase as a possible target [J].
Cao, M ;
WesterhausenLarson, A ;
Niyibizi, C ;
Kavalkovich, K ;
Georgescu, HI ;
Rizzo, CF ;
Hebda, PA ;
StefanovicRacic, M ;
Evans, CH .
BIOCHEMICAL JOURNAL, 1997, 324 :305-310
[6]
CLONING, CHARACTERIZATION, AND EXPRESSION OF A CDNA-ENCODING AN INDUCIBLE NITRIC-OXIDE SYNTHASE FROM THE HUMAN CHONDROCYTE [J].
CHARLES, IG ;
PALMER, RMJ ;
HICKERY, MS ;
BAYLISS, MT ;
CHUBB, AP ;
HALL, VS ;
MOSS, DW ;
MONCADA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11419-11423
[7]
SUPPRESSION OF ADJUVANT-INDUCED ARTHRITIS BY SELECTIVE-INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE [J].
CONNOR, JR ;
MANNING, PT ;
SETTLE, SL ;
MOORE, WM ;
JEROME, GM ;
WEBBER, RK ;
TJOENG, FS ;
CURRIE, MG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 273 (1-2) :15-24
[8]
deMello SBV, 1997, INFLAMM RES, V46, P72
[9]
Proinflammatory cytokines [J].
Dinarello, CA .
CHEST, 2000, 118 (02) :503-508
[10]
Dougados M, 2001, ARTHRITIS RHEUM-US, V44, P2539, DOI 10.1002/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO